Versigent (NYSE:VGNT) Posts Earnings Results, Beats Estimates By $0.34 EPS

Versigent (NYSE:VGNTGet Free Report) announced its quarterly earnings results on Tuesday. The company reported $1.92 EPS for the quarter, beating the consensus estimate of $1.58 by $0.34, Zacks reports. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.29 billion.

Here are the key takeaways from Versigent’s conference call:

  • Versigent reported strong second-quarter results, with net sales up 11% year over year to $2.4 billion, adjusted EBITDA up 25% to $272 million, and margin expanding 120 basis points to 11.1%. Underlying adjusted sales growth was approximately 5%, outpacing relatively flat-to-down global automotive production.
  • The company cited robust commercial momentum, including $2.8 billion in second-quarter bookings and 39 large-scale program launches with more than 99% quality and on-time delivery. Growth was particularly strong in the Americas and Asia-Pacific, supported by customer launches and China-related vehicle exports.
  • Versigent raised its 2026 sales guidance to $9.4 billion-$9.6 billion, primarily due to higher copper pass-throughs and favorable foreign exchange, but maintained adjusted EBITDA guidance of $950 million-$1.03 billion because those macro benefits are not expected to materially improve profitability. The company also reaffirmed free cash flow guidance of $200 million-$300 million.
  • Management expects second-half pressure from lower global automotive production, customer-specific schedule reductions, softer EMEA demand, and temporary volume and absorption impacts from an unusually high number of program launches. European adjusted sales declined 11% in the quarter, prompting targeted actions to improve regional competitiveness.
  • The company initiated a quarterly dividend of $0.13 per share and has $250 million remaining under its share-repurchase authorization, supported by its projected cash generation and approximately $1 billion of cumulative free cash flow from 2026 through 2028. Management also identified commercial vehicles, agriculture, battery energy storage, and robotics as potential longer-term growth opportunities not included meaningfully in its 2028 outlook.

Versigent Trading Up 2.0%

Shares of Versigent stock opened at $46.71 on Wednesday. The business’s 50-day moving average price is $43.38. Versigent has a 1-year low of $26.34 and a 1-year high of $50.88.

Versigent Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Investors of record on Friday, September 4th will be given a dividend of $0.13 per share. The ex-dividend date is Friday, September 4th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.1%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on VGNT shares. BNP Paribas Exane began coverage on Versigent in a research report on Tuesday, April 28th. They issued an “outperform” rating and a $41.00 price target on the stock. Wall Street Zen upgraded Versigent to a “hold” rating in a research note on Saturday, April 18th. Deutsche Bank Aktiengesellschaft raised Versigent from a “hold” rating to a “buy” rating and set a $50.00 price target on the stock in a research report on Tuesday, July 7th. Fox Advisors cut Versigent from an “overweight” rating to an “equal weight” rating in a research report on Wednesday. Finally, Oppenheimer set a $50.00 price objective on shares of Versigent in a research note on Tuesday, July 21st. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $50.58.

Check Out Our Latest Research Report on VGNT

Featured Stories

Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.